Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Nicotine · Habitrol Step 3, Nicorette Fruit Chill Nicotine Polacrilex

Small molecule · developed by Dr Reddys Labs Sa

Approved FDA, Nov 1991
1 Registered trials

What is Nicotine?

Nicotine is a systemically delivered agent, given as nicotine replacement therapy in oral and transdermal forms, intended to reduce the urge to smoke or chew tobacco. It is studied in smoking cessation, where it reduces withdrawal symptoms such as nicotine craving.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Habitrol Step 3, Nicorette Fruit Chill Nicotine Polacrilex, Nicotine Transdermal System Step 3, Prostep
Drug type
Small molecule
Pathways
nicotine withdrawal symptoms, nicotine craving
Therapy area
Respiratory
Developer
Dr Reddys Labs Sa
In trials of
EVO
FDA status
Approved as Habitrol Step 3, Nicorette Fruit Chill Nicotine Polacrilex, Nicotine Transdermal System Step 3 (November 27, 1991), NDA020076 · FDA label

✅ FDA-approved uses

From the indications section of the FDA label (version of Dec 30, 2024). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT00622752 Phase 2 Smoking Cessation Completed EVO

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Smoking Cessation

Sources

Updated Nov 15, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.